The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
| Autor: | Liposits, G., Skuladottir, H., Ryg, J., Winther, S. B., Möller, S., Hofsli, E., Shah, C-H., Oestergaard, L. Poulsen, Berglund, A., Qvortrup, C., Osterlund, P. J., Johansen, J. S., Glimelius, B., Sorbye, H., Pfeiffer, P. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Zdroj: | Liposits, G, Skuladottir, H, Ryg, J, Winther, S B, Möller, S, Hofsli, E, Shah, C-H, Oestergaard, L P, Berglund, A, Qvortrup, C, Osterlund, P J, Johansen, J S, Glimelius, B, Sorbye, H & Pfeiffer, P 2022, ' The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study ', Annals of Oncology, vol. 33, no. Suppl. 7, 345P, pp. S694 . https://doi.org/10.1016/j.annonc.2022.07.483 |
| DOI: | 10.1016/j.annonc.2022.07.483 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|